The Elliot's Neurological Specialties clinic combines medical treatments to slow MS progression with holistic approaches to ...
NICE recommends natalizumab as a new treatment for adults with highly active relapsing-remitting multiple sclerosis ...
England's NICE is recommending natalizumab, sold as Tysabri and Tyruko, as an NHS-covered treatment option for people with ...
MS research suggests the disease may be divided into two biological subtypes that differ in how early and aggressively nerve ...
Monoclonal antibody DMTs, especially anti-CD20 therapies, effectively prevent relapses but have limited impact on progressive MS. Progressive MS involves compartmentalized CNS inflammation, with ...
Scientists have used AI to identify two novel subtypes of multiple sclerosis (MS), which could offer new, targeted treatments for patients. MS affects around 2.8 million people across the world. It’s ...
Multiple sclerosis (MS) is a chronic autoimmune disease in which the immune system attacks the body’s nerves. Immune cells ...
Hundreds of people gathered at Hammonasset Beach State Park for the annual Walk MS event on Sunday. The Walk MS, hosted by the National MS Society, is an opportunity for people with Multiple Sclerosis ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback